Pre-IPO deals revive as Indian issuers line up

Indian companies are stepping back into pre-IPO placements in July after activity cooled sharply in the first half of 2026, with issuers seeking institutional commitments before launching public share sales. Reaction pending.

Data showed three companies have raised funds before planned initial public offerings so far this month. Karamtara Engineering raised ₹75 crore, Biorad Medisys raised about ₹400 crore and Silver Consumer Electricals raised ₹150 crore.

SBI Funds eyes ₹2,000 crore round

At least four more companies are preparing institutional placements in the weeks ahead. SBI Funds Management is considering a pre-IPO placement of nearly ₹2,000 crore before its IPO, while Chennai-based Neuberg Diagnostics aims to raise ₹500 crore over the next three to six months.

The revival follows a steep slowdown from late 2025. Data showed pre-IPO activity reached ₹20,412 crore in the December quarter, then fell to ₹3,156 crore in the March quarter and ₹565 crore in the June quarter.

Bankers said these rounds can help issuers test valuation, broaden the shareholder base and reduce execution risk before a listing. For private equity holders, a placement can also create an earlier route to sell part of a stake before the IPO book opens.

For India’s equity market, a sustained pickup would point to firmer institutional appetite for new listings and improve visibility for deal pipelines. If demand weakens again, issuers may scale back placement sizes or delay IPO timing; Neuberg’s stated funding window runs to January 8, 2027.